Throughout the year, Capsugel hosts and participates in numerous webinars and virtual conferences. Each of these activities gives us an opportunity to showcase our latest products and services, build relationships with customers and partners, and share and gain invaluable insights.
Webinar |
---|
Paving Your Road to Clean Label: From Formulation to Manufacturing and MarketingMay 27, 2015 3 PM CET (9 AM EDT) Market Segment: Dietary Supplement Today’s consumers are more concerned about what is in their food and how it is made. As a culture for checking labels emerges, food supplement manufacturers are increasingly exploring opportunities for clean label products.
Paving Your Road to Clean Label: From Formulation to Manufacturing and MarketingMay 27, 2015 3 PM CET (9 AM EDT) Market Segment: Dietary Supplement Click here for access |
Innovations to Optimize Delivery of ProbioticsMay 21, 2015 11 AM ET (5 PM CET) Market Segment: Dietary Supplement Consumers are driving changes in the health and nutrition and seek products that ensure success in their goals for a healthier lifestyle. With increased use of probiotics and consumer concerns about effective products for digestive health, product developers and brand managers are seeking ways to optimize delivery for probiotic and other acid-sensitive ingredients. Capsugel’s portfolio of dosage delivery systems leverages the latest science and engineering to help you capture your share of the market. Discover ways to increase your product’s effectiveness, consumer satisfaction and shelf stability. Innovations to Optimize Delivery of ProbioticsMay 21, 2015 11 AM ET (5 PM CET) Market Segment: Dietary Supplement Click here for access |
Biologic Comparison of a Novel Inhaled Insulin DPI Formulation to Exubera™April 30, 2015 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Inhaled peptides and proteins have promise for respiratory and systemic disease treatment such as diabetes. This class of molecules is particularly well suited to formulation and processing by spray drying to achieve respirable engineered particles. This webinar will discuss important aspects of formulation and process development for an inhaled biotherapeutic as well as describe important pre-clinical in vivo model methodologies required to understand biologic performance. Specifically, it will discuss pharmacokinetic and pharmacodynamic performance after pulmonary delivery of a DPI, providing an overview of a recent case study, demonstrating in vitro and in vivo inhalation performance of a novel spray-dried powder of insulin in comparison to Exubera™. Speakers:
Biologic Comparison of a Novel Inhaled Insulin DPI Formulation to Exubera™April 30, 2015 11 AM ET (5 PM CET) Market Segment: Pharmaceutical Click here for access |
Global Product Development in Capsule-based Dry Powder Inhaler for Emerging MarketsApril 16, 2015 4 PM CET (10 AM ET) Market Segment: Pharmaceutical Product development in dry powder inhalation using capsules has grown exponentially around the world as formulators recognize the cost and flexibility advantages, especially for emerging markets. This webinar will overview challenges and opportunities in new product and generic development, identify specific devices and capsule customization based on drug requirements. Who will benefit from attending? Speakers:
Global Product Development in Capsule-based Dry Powder Inhaler for Emerging MarketsApril 16, 2015 4 PM CET (10 AM ET) Market Segment: Pharmaceutical Click here for access |
Quality Risk Management for ExcipientsMarch 31, 2015 9:45 AM EDT (3:45 PM CET) Market Segment: Pharmaceutical As demand for high-quality excipients continues to grow, Capsugel will share its best practices and key learnings as a leading high-quality excipient manufacturer in a special session during the Excipients Innovations 2015 Online Event, Tuesday, March 31, 2015. The free annual event engages global participants about the future demands that will drive the drug excipients market in the future. See the webinar here: Quality Risk Management for ExcipientsMarch 31, 2015 9:45 AM EDT (3:45 PM CET) Market Segment: Pharmaceutical Click here for access |